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Abstract
Background The European Organisation of Research and
Treatment of Cancer (EORTC) Quality of Life Group is
developing computerized adaptive testing (CAT) versions
of all EORTC Quality of Life Questionnaire (QLQ-C30)
scales with the aim to enhance measurement precision.
Here we present the results on the field-testing and psy-
chometric evaluation of the item bank for cognitive func-
tioning (CF).
Methods In previous phases (I–III), 44 candidate items
were developed measuring CF in cancer patients. In phase
IV, these items were psychometrically evaluated in a large
sample of international cancer patients. This evaluation
included an assessment of dimensionality, fit to the item
response theory (IRT) model, differential item functioning
(DIF), and measurement properties.
Results A total of 1030 cancer patients completed the 44
candidate items on CF. Of these, 34 items could be
included in a unidimensional IRT model, showing an
acceptable fit. Although several items showed DIF, these
had a negligible impact on CF estimation. Measurement
precision of the item bank was much higher than the two
original QLQ-C30 CF items alone, across the whole con-
tinuum. Moreover, CAT measurement may on average
reduce study sample sizes with about 35–40% compared to
the original QLQ-C30 CF scale, without loss of power.
Conclusion A CF item bank for CAT measurement con-
sisting of 34 items was established, applicable to various
cancer patients across countries. This CAT measurement
system will facilitate precise and efficient assessment of
HRQOL of cancer patients, without loss of comparability
of results.
Keywords Computerized adaptive testing  Cancer 
Cognitive functioning  Item bank  Health-related quality
of life  EORTC QLQ-C30
Introduction
One of the most frequently used tools to measure health-
related quality of life (HRQoL) in cancer patients is the
European Organisation for Research and Treatment of
Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
[1]. This questionnaire comprises 30 items organized into
five functional scales (physical, role, emotional, cognitive,
and social functioning), three symptom scales (fatigue,
nausea and vomiting, pain), one overall health/quality-of-
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life scale, and six single items (dyspnea, insomnia, appetite
loss, constipation, diarrhea, and financial difficulties).
Traditionally, patients complete all 30 items, allowing
comparability of scores across patients. However, limita-
tions of this method are that some patients may have to
answer irrelevant questions and that certain domains may
be measured with less precision than desired.
These limitations can be overcome with computerized
adaptive testing (CAT) [2–4]. CAT is a method to select an
individual item set for each patient. Based on the patient’s
responses to previous items, the computer program selects
a new item from an item bank, aiming to maximize the
information obtained. The advantage of CAT is that fewer
items are needed to obtain precise measurement and that
scores across patients are directly comparable, even if
patients do not answer the same subset of items. This is
enabled with item response theory (IRT) methods [5].
Currently, the EORTC quality of life group (QLG) is
developing CAT versions of all EORTC QLQ-C30 scales,
except the overall health/quality-of-life scale [6–15]. To do
so, a unidimensional item bank is developed for each scale,
consisting of items covering the same aspects of the
dimension as reflected by the items of the original scale. To
ensure a homogeneous format and compatibility of items
with the original QLQ-C30 items, new items are formu-
lated with the same response format and timeframe as the
original items.
The EORTC CAT development takes place in an
international, cross-cultural setting and consists of four
phases: (I) conceptualization and literature search, (II)
operationalization, (III) pre-testing, and (IV) field-testing.
The first three phases for the development of an item bank
for the QLQ-C30 cognitive functioning (CF) scale have
been completed [6]. Phase I retrieved 294 items from
existing instruments focusing on the subdomains memory
and concentration. Following a multistep item selection
procedure, most items were excluded, mainly because of
redundancy. The steps in phase II included the catego-
rization of items into aspects of cognitive complaints or
‘other’ (step 1), deletion of redundant items (step 2), for-
mulation of items fitting the QLQ-C30 item style (step 3),
rating of the items following the continuum of cognitive
complaints (step 4), generation of new items in case of
insufficient coverage of the measurement continuum (step
5), and lastly expert evaluation, in which items were
assessed for their relevance to the construct of cognitive
complaints, their appropriateness, completeness, and for
whether they were clear and well defined (step 6). In phase
III, the preliminary items list was pre-tested in a sample of
international cancer patients to determine the appropriate-
ness of the selected items for the target population and to
ensure content validity. Based on the remaining items, 43
new items were formulated. These were pre-tested in a
group of cancer patients. Phase III resulted in a list of 44
items (including the two original QLQ-C30 CF items)
measuring CF in cancer patients. Here we report the results
on the phase IV field-testing and psychometric evaluations
of these 44 candidate items for the CF item bank, which
will be used in CAT measurement.
Methods
The methods used are in accordance with the general
approach used for psychometric analyses of item banks for
CAT, as previously reported for other EORTC QLQ-C30
scales [9, 11–14].
Sample
The EORTC CAT is developed for international use in
cancer patients. According to the guidelines, a heteroge-
neous sample of cancer patients across Europe (Denmark,
Poland, France, and the United Kingdom) was included
with different diagnoses, stages of disease, treatment
modalities, and sociodemographic factors. To be eligible,
patients had to be over 18 years with a histologically ver-
ified cancer, and were required to be physically and men-
tally fit enough (no formal screening procedure was used,
but patients’ health status was judged by the physician or
researcher) to complete the questionnaire. To assure suf-
ficient coverage of patients with different characteristics
and to obtain precise calibration of the IRT model, a
minimum of 1000 patients were included [16–18]. Local
ethics committees of the participating countries approved
the study and written informed consent was obtained
before participation.
Questionnaire
Patients were asked to complete a questionnaire consisting
of the 42 newly developed items on CF [6], next to the two
original CF items, and five debriefing items asking whether
patients found any of the items problematic. Twelve out of
the 42 items were related to concentration and 30 to
memory, and were fitted to the QLQ-C30 item style with a
recall period of a week and the use of a 4-point Likert scale
ranging from ‘not at all’ to ‘very much.’ In addition,
information on patient and disease characteristics was
collected.
Statistical analysis
The psychometric analyses for the selection and calibration
of the items for the CF item bank consisted of six steps:
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1. Descriptive and basic statistical analyses
Descriptive statistics were used to define the patient
population, to calculate response rates and item means and
standard deviations (SD), and to determine correlations
between the items and the original QLQ-C30 CF sum scale.
2. Evaluation of dimensionality and local dependence
The aim was to find a unidimensional solution including
both original QLQ-C30 CF items and as many new items
as possible. Dimensionality of the items was assessed using
factor analysis methods for ordinal categorical data [19]
including exploratory evaluations of dimensionality
examining eigenvalues and scree plot [20]. These were
followed by confirmatory methods where a reasonable fit of
a unidimensional model was defined as follows: the root
mean square of approximation (RMSEA)\0.10, the
Tucker-Lewis Index (TLI)[0.90 and the comparative fit
index (CFI)[0.90 [21, 22]. Since standard IRT models
require that items are locally independent (i.e., item
responses are independent when controlling for the overall
level of CF), we also evaluated the residual correlations
from the final factor model. Residual correlations\0.20
were defined as indication of local independence [23].
3. Calibration of the IRT model and evaluation of item fit
Besides local independence, IRT models also assume
monotonicity. This is the increasing likelihood for an item
response reflecting good CF with increasing CF score.
Monotonicity was evaluated by checking the average item
score in relation to the ‘rest score,’ i.e., the sum score of all
items except the evaluated item. Compliance with mono-
tonicity implies that an average item score should not
decrease for increasing values of the rest score [24].
A polytomous IRT model, the generalized partial credit
model (GPCM) [25], was used as basis for the CF CAT. In
this type of model, each item has a slope parameter to
describe the item’s ability to discriminate between subjects
with different levels of CF, and a set of threshold param-
eters which define where on the CF continuum neighbor
response options are equally likely to be selected. The
average of an item’s threshold is termed the item location.
Parscale (Scientific Software International [SSI], Sko-
kie, IL, USA) was used to estimate the IRT model [18].
Item fit was examined using the item-fit test S-v2 [26]
implemented for polytomous items in the SAS macro
IRTfit [27]. In addition, bias and indices of fit were eval-
uated, by calculating the difference between expected and
observed item responses and the infit and outfit indices,
respectively [28]. Infit and outfit are both statistics based on
squared standardized residuals across patients, i.e., they
reflect the difference between the model expected respon-
ses and the actual observed responses to an item. Although
similar, the infit is more sensitive to responses from
respondents with CF scores close to the item’s location,
while the outfit is more sensitive to unexpected responses
far from the item’s location. The infit is therefore partic-
ularly important, since it reflects the principle of CAT
measurement, where items closest to the respondents actual
CF score are asked. Infit and outfit values between 0.7 and
1.3 were defined acceptable. Although smaller values
(\0.07) indicate ‘overfit’ (i.e., better fit than expected
statistically, because of redundancy), these are not as
worrisome as larger values ([1.3), which indicate misfit to
the model.
4. Test for differential item functioning
Differential item functioning (DIF), i.e., whether items
are perceived and behave similarly in different patient
groups, was tested using ordinal logistic regression meth-
ods for gender, age, country, cancer site, cancer stage,
current treatment, cohabitation, educational level, and
work. Each item was entered as the dependent variable and
group (DIF) variables as independent variables, controlling
for the CF score estimated using the calibrated IRT model
in the previous step. DIF was defined potentially relevant if
p\ 0.001 (because of a large sample and multiple testing)
and if the regression coefficient for the group variable was
moderate to large, i.e., b[ 0.64 (for group variables with
more than two categories, at least two categories’ coeffi-
cients should differ[0.64) [29, 30]. For each item, each
group variable was first tested individually for both uni-
form and non-uniform DIF. Because confounding of group
variables may cause false-positive DIF findings, significant
group variables in the individual tests were entered
simultaneously in a multivariable logistic regression
model. Only the findings of these models are reported.
Moreover, the possible effect of DIF findings on the
estimation of CF was evaluated [31]. Although DIF may
have significant impact on item level, this may be
neglectable on scale level. Therefore, CF scores obtained
with the model in step 3 (not accounting for DIF) were
compared with scores obtained with a model accounting
for DIF. If the CF estimates of these two models differed
more than the median standard error of the CF estimates
(the median standard error used to represent the general
uncertainty of the CF estimates), referred to as ‘salient
scale-level differential functioning’ [11, 12, 14, 31], this
was regarded as problematic.
5. Evaluation of discarded items
To ensure that items have not been discarded erro-
neously in the previous steps, the discarded items were
added one at the time to the list of items obtained after step
4 in order to evaluate whether the item still showed misfit.
If discarded erroneously, items could be included again.
Qual Life Res (2017) 26:2919–2929 2921
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6. Evaluation of measurement properties of the CAT
The information function, a measure of the measure-
ment precision of an item or set of items at different levels
of CF, of the final CF item bank was calculated. High
measurement precision was defined as an information
score[20, corresponding to a reliability of[95% [32].To
further evaluate the measurement properties of the final CF
CAT, simulations of CAT administration based on the
collected data were performed. CATs were simulated with
1 up to 33 items (total of 33 simulations) and then the
scores based on these CATs were compared with the score
based on all 34 items. Relative validity (RV), the ratio of
two test statistics for comparing two groups, of these CATs
as compared to the QLQ-C30 CF scale for detecting
expected group differences was estimated [33]. When
using the t test statistic of each CAT as the numerator and
the t-test for the QLQ-C30 CF scale as denominator, an RV
value[1 indicates that smaller samples may be needed
using the CAT measures to obtain the same power as with
the QLQ-C30 CF scale. To evaluate the RV of the CATs
compared to the QLQ-C30 scale, we compared groups
expected to differ (known groups) based on the following
hypotheses: patients not on treatment would have better CF
than patients on treatment, patients with stage I or II would
have better CF than patients with stage III or IV disease,
younger patients would have better CF than older patients,
patients working would have better CF than patients not
working, and patients with more years of education would
have better CF than those with less years. Only known
group variables that were significant for at least one of the
outcomes (QLQ-C30 CF score or one of the CAT-based
scores) were used to calculate RVs. In addition to these
evaluations based on the observed data, we also evaluated
the RV of the CATs based on simulated data across dif-
ferent groups and group sizes [9].
Results
A total of 1030 cancer patients were included in this study.
Detailed description of patient characteristics is presented
in Table 1. The results follow the stepwise outline as
presented in the Methods section.
1. Descriptive and basic statistical analyses
Response rates for the 44 items ranged from 99.2 to
100%, and item means from 1.1 to 2.0 on a scale from 0 to
3, with higher scores reflecting more cognitive difficulties.
In general, patients experienced at most minor cognitive
difficulties. Only 7% of the patients reported no problems
on any item. All new items correlated[0.4 with the orig-
inal QLQ-C30 CF scale, and all but two items (item 23,
r = 0.47; item 43, r = 0.56) correlated[0.6. No items
were rated as difficult to understand, annoying, confusing,
upsetting, or intrusive by more than 4 patients (0.4%).
Table 1 Clinical characteristics of the 1030 participating patients
Characteristic N (%)/mean
Age in years, mean (range) 63 (26–97)
Gender
Men 488 (47.4%)
Women 542 (52.6%)
Country
Denmark 138 (13.4%)
France 158 (15.3%)
Poland 280 (27.2%)
United Kingdom 454 (44.1%)
Cancer site
Breast 237 (23.0%)
Gastrointestinal 144 (14.0%)
Gen-urinary 171 (16.6%)
Gynecological 99 (9.6%)
Hematological 51 (5.0%)
Head and neck 87 (8.4%)
Lung 33 (3.2%)
Other 208 (20.2%)
Cancer stage
I–II 615 (59.7%)
III–IV 409 (39.7%)
Unknown 6 (0.6%)
Current treatment
Chemotherapy 378 (36.7%)
Other treatment 337 (32.7%)
No treatment 314 (30.5%)
Unknown 1 (0.1%)
Cohabitation
Living with a partner 750 (72.8%)
Living alone 267 (25.9%)
Missing 13 (1.3%)
Educational level
0–10 years 311 (30.2%)
11–13 years 269 (26.1%)
14–16 years 221 (21.5%)
[16 years 225 (21.8%)
Missing 4 (0.4%)
Work
Fulltime 337 (32.7%)
Part-time 76 (7.4%)
Retired 431 (41.8%)
Other 184 (17.9%)
Missing 2 (0.2%)
2922 Qual Life Res (2017) 26:2919–2929
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Overall, 97% of the patients found all 44 items unprob-
lematic. Based on these results, no items were deleted in
this step.
However, seven items had\10 responses in the ‘very
much’ category. To avoid too low numbers in the IRT
analyses, the ‘quite a bit’ and ‘very much’ categories were
combined and used in further analyses for these items.
2. Evaluation of dimensionality and local dependence
Exploratory factor analysis revealed one clearly domi-
nating factor (eigenvalue = 28.1), explaining 64% of the
total variation. However, two additional factors also had
eigenvalues[1, explaining 4.7 and 2.4% of the variance,
respectively (see also Supplementary Table 1). The scree
plot indicated that two factors were required to explain the
variation in the data. This was supported by the finding that
a one-factor solution showed poor fit indices:
RMSEA = 0.104, CFI = 0.872, and TLI = 0.985. Alter-
natively, a two-factor model seemed to fit well:
RMSEA = 0.065, CFI = 0.936, and TLI = 0.994. In this
two-factor model, the two original QLQ-C30 CF items load
on different factors: one primarily focusing on memory and
the other focusing primarily on concentration. As the aim
was a unidimensional item bank covering both subdomains
(as the original QLQ-C30 CF scale), the selection strategy
in the confirmatory factor analysis focused on discarding
items having very low loading on one factor in a two-factor
solution; items tapping on both subdomains would make
the item bank more homogenous while still covering both
subdomains. For example, the item ‘Have you had diffi-
culty remembering the names of common things?’ did not
seem to involve concentration and was therefore discarded,
while the item ‘Have you had difficulty performing two
tasks simultaneously, e.g. having a conversation while
cooking?’ seemed to cover both concentration and memory
and was included. Using this strategy and the predefined
criteria for model fit (i.e., RMSEA\0.10, and TLI and
CFI[0.90), 34 items could be included in a unidimen-
sional model (RMSEA = 0.095, CFI = 0.903, and
TLI = 0.989), explaining 66% of the total variation
(eigenvalue = 22.5).
All 561 residual correlations for the 34 items
were\0.20 except one which was 0.24. This indicates no
or at most trivial local dependence among the retained
items.
3. Calibration of the IRT model and evaluation of item fit
Although some items exhibited minor deviations from
monotonicity, likely due to random variation, no items
were deleted. Therefore, a GPCM was calibrated to the 34
items (details on item fit are summarized in Table 2). The
item-fit tests showed that all items had an acceptable fit
(p[ 0.10 for v2 test) and they were therefore retained in
the model. Next, bias estimates were all close to zero,
indicating no or negligible systematic bias. The infit ranged
from 0.91 to 1.15 and the outfit from 0.73 to 1.20. Thus,
results indicate acceptable fit for all 34 items.
4. Test for differential item functioning
Eighteen items showed significant DIF (all uniform), but
only for age, country, or work (Table 3). Most differences
were found for country (n = 13), followed by age (n = 7)
and work (n = 1). Three items, showing the most pro-
nounced indications of DIF, were evaluated for their pos-
sible effect on CF estimation. Results showed that the
potential DIF for these items had negligible impact on CF
estimation (CF scores accounting for and not accounting
for DIF all correlated C0.99). Therefore, all items were
retained in the model.
5. Evaluation of discarded items
Adding any of the ten discarded items to the model
again, resulted in significantly poorer model fit and lack of
unidimensionality. Therefore, no items were restored, and
the 34 items (Table 2) comprise the final item bank. The
item bank includes 11 items on concentration and 23 items
on memory.
6. Evaluation of measurement properties
In Fig. 1, the test information function for the 34 items
in the final model is displayed as well as the information
function on the two original QLQ-C30 CF items. CF scores
ranged from -3.7 (‘very much’ on all items) to 1.7 (‘not at
all’). The total test scale has very high measurement pre-
cision for scores from -3.2 to 0.5 (about 3.7 standard
deviation units). This means that the item bank is partic-
ularly precise for patients with at least minor cognitive
difficulties, and less precise for patients with very few
cognitive difficulties. The item bank results in markedly
higher measurement precision than the two original QLQ-
C30 CF items across the whole continuum.
The CAT simulations based on collected data showed
that scores based on three or more items correlated highly
([0.90) with the score based on all items (Fig. 2). Average
RV scores across known groups for the observed and
simulated data are shown in Supplementary Figs. 1 and 2,
respectively. Average RV scores across known groups for
the observed and simulated data combined, across all
evaluated settings (different group sizes and group differ-
ences), are shown in Fig. 3. For the observed data our
hypothesized known group differences were confirmed
except that we did not observe any differences in CF
between working and not working patients. Across the
remaining known groups, the average estimated savings in
the sample size without loss of power, based on the
observed data, was close to 50% for CATs of all lengths
Qual Life Res (2017) 26:2919–2929 2923
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(Supplementary Fig. 1). Simulated data showed savings in
the sample size up to about 25% compared to the QLQ-C30
scale (Supplementary Fig. 2). These were very consistent
across simulated sample sizes and there were only minor
variations across known groups. Although estimated sav-
ings varied across methods (&50 vs. &25%), simulations
Table 2 Parameter estimates and fit statistics for the 34 items in the final IRT model
Item Slope Location Item fit
p value
Infit Outfit
Item 1 Have you had difficulty performing two tasks simultaneously, e.g. having a conversation
while cooking?
1.55 -1.57 0.813 1.01 1.03
Item 3 Have you been distracted by thoughts when you should have been concentrating on
something else?
1.73 -0.99 0.726 0.97 0.92
Item 5 Have you had difficulty remembering what date it was? 1.59 -1.41 0.640 1.06 0.97
Item 8 Have you had difficulty remembering what somebody told you a few minutes earlier? 2.01 -1.52 0.980 0.98 0.90
Item 9 Have you had difficulty remembering what you were going to say while you were
talking?
2.25 -1.23 0.392 1.01 0.89
Item 10 Have you had difficulty remembering what happened the last few days? 1.97 -1.53 0.965 0.99 0.83
Item 11 Have you walked into a room but forgotten what you went for? 1.78 -0.83 0.609 0.98 0.94
Item 12 Have you had difficulty remembering the names of relatives, friends, or other people
you see regularly?
1.24 -1.56 0.689 0.98 0.90
Item 13 Have you had difficulty remembering what you initially were doing if you started to do
something else in the meantime?
2.25 -1.56 0.714 1.01 0.88
Item 14 Have you had difficulty remembering what you were doing when you were interrupted? 2.66 -1.36 0.602 0.99 0.80
Item 15 Have you had difficulty in concentrating on things, like reading a newspaper or
watching television? (q20)
1.84 -1.45 0.106 1.05 1.00
Item 16 Have you been reading something and had to read the same lines again because you
were distracted?
1.83 -1.11 0.374 0.96 0.92
Item 18 Have you had difficulty remembering things? (q25) 2.68 -1.00 0.880 0.97 0.86
Item 19: Have you had difficulty maintaining concentration even when something really
interested you?
3.15 -0.91 0.588 0.99 0.84
Item 24 Have you been forgetful? 2.52 -1.12 0.139 1.03 0.96
Item 25 Have you had difficulty paying attention on a task or a conversation for a longer period
of time?
2.48 -1.29 0.718 0.93 0.85
Item 26 Have you had difficulty recognising relatives, friends, or other people you see regularly? 1.63 -2.40 0.973 1.15 1.20
Item 27 Have you had difficulty remembering what someone just told you? 3.32 -1.14 0.554 1.07 0.81
Item 28 Have you had difficulty paying attention for as long as you wanted or needed to? 2.50 -1.36 0.389 1.05 1.02
Item 30 Have you had difficulty remembering new information, like a person’s name or simple
instructions?
2.31 -1.30 0.590 0.97 0.87
Item 31 Have you had difficulty remembering to take things you needed with you? 1.66 -1.19 0.260 0.99 0.90
Item 32 Have you become distracted from a task before finishing it? 2.08 -1.55 0.412 0.93 0.84
Item 33 Have you had difficulty remembering whether you had already done something? 2.48 -1.66 0.998 1 0.86
Item 34 Have you had difficulty remembering something you had just said? 2.62 -1.30 0.964 0.94 0.73
Item 35: Have you had difficulty remembering to pass on a message or remind someone of
something?
1.82 -1.55 0.764 0.93 0.85
Item 36 Have you had difficulty maintaining concentration even when doing something
important?
3.74 -1.46 0.837 0.98 0.90
Item 37 Have you had difficulty remembering what you were just thinking? 2.91 -1.49 0.918 0.94 0.81
Item 38 Have you had difficulty gathering your thoughts? 2.15 -1.05 0.334 0.91 0.89
Item 39 Have you had difficulty remembering to do the things you had planned to do? 2.78 -1.47 0.995 0.95 0.79
Item 40 Have you had difficulty remembering what weekday it was? 1.80 -1.45 0.933 0.96 0.87
Item 41 Have you had difficulty remembering what a text you were reading was about? 1.88 -1.76 0.686 1.05 0.94
Item 42 Have you had difficulty remembering what you did a few days earlier? 2.22 -1.56 0.562 1.01 0.94
Item 43 Have you forgotten to do routine things such as turning off the light or locking the door? 1.20 -1.76 0.926 0.96 0.88
Item 44 Have you had difficulty staying focused on a task or an activity? 3.01 -1.40 0.363 0.95 0.74
2924 Qual Life Res (2017) 26:2919–2929
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on both observed and simulated data indicated clear
reductions in sample size requirements when using CAT to
measure CF. On average across methods, the savings were
about 35–40% when asking two or more items (Fig. 3).
Discussion
The overall aim of the EORTC CAT project is to develop
item banks for all EORTC QLQ-C30 scales, which can be
used for CAT. In this study, we report the psychometric
evaluation of 44 candidate items for the CF item bank,
which were developed in previous phases [6]. The factor
analysis indicated that the candidate items are divided into
two subdimensions: memory and concentration. However,
34 of the 44 items sufficiently covered both subdimensions
to be included into a unidimensional model. All 34 items
had an acceptable fit to the IRT model. Although several
items showed DIF, this DIF had negligible impact on CF
estimation. Thus, CF scores based on the item bank
can be compared across studies, irrespective of patient
characteristics.
Table 3 Results of the DIF analysis
Item DIF b p value DIF b p value
Item 1 Country -0.76 (Poland vs. rest) \0.0001
Item 3 Age 0.80 (C70 vs. rest) \0.0001
Item 5 No DIF
Item 8 Country 1.15 (Poland vs. rest) \0.0001
Item 9 No DIF
Item 10 Country 1.33 (Poland vs. rest) \0.0001
Item 11 No DIF
Item 12 Age -1.26 (\50 vs. C50) \0.0001
Item 13 No DIF
Item 14 No DIF
Item 15 (q20) Age 0.93 (\70 vs. C70) \0.0001 Country 0.93 (Poland vs. rest) \0.0001
Item 16 No DIF
Item 18 (q25) Age 1.67 (\40 vs. C40) \0.0001
Item 19 Work 0.69 (Retired vs. rest) 0.0002
Item 24 Country -0.74 (Poland vs. rest) \0.0001
Item 25 No DIF
Item 26 No DIF
Item 27 No DIF
Item 28 Country -1.56 (Poland vs. rest) \0.0001
Item 30 Age -1.38 (\40 vs. C40) 0.0020 Country -0.85 (Denmark vs. rest) \0.0001
Item 31 No DIF
Item 32 No DIF
Item 33 No DIF
Item 34 Country -0.82 (Poland vs. rest) \0.0001
Item 35 No DIF
Item 36 Country 0.71 (Poland vs. rest) 0.0006
Item 37 Country 0.95 (Denmark vs. rest) \0.0001
Item 38 Age 0.75 (\50 vs. C50) 0.0002 Country 2.57 (Poland vs. rest) \0.0001
Item 39 No DIF
Item 40 No DIF
Item 41 Country 1.08 (Denmark & France vs. Poland & United Kingdom) \0.0001
Item 42 Country 0.78 (Denmark & France vs. Poland & United Kingdom) \0.0001
Item 43 No DIF
Item 44 Age 1.49 (\40 vs. C40) 0.0002
One beta for each group variable (e.g., country) is presented which summarizes the potential DIF, as well as the reference category that was used
in each case
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The measurement precision of the CF item bank was
high for patients reporting at least minor cognitive diffi-
culties, and somewhat less precise for patients reporting
trivial cognitive difficulties. The majority (73%) of the
cancer patients in this study experienced at most minor
cognitive difficulties (here defined as a CF score\-0.7,
corresponding to answering ‘a little’ to all 34 items in the
final item bank). This suggests that the measurement
precision for general cancer patients may be suboptimal.
The results did show that CAT measurement will be very
precise in the subset of cancer patients with some cog-
nitive impairment. This means that CAT could be
particularly useful in patients with primary brain tumors
and patients with systemic cancer with central nervous
system metastases or treatment-related cognitive deficits
[34–41]. However, primary brain tumor patients were not
included in the patient sample and it is unknown how
many patients had brain metastases or treatment-related
cognitive deficits, limiting generalizability of the results
(i.e., whether the results are also applicable to brain tumor
patients). From a methodological point of view, new
items that are relevant for patients with trivial cognitive
difficulties could be constructed and added to the item
bank in order to enhance measurement precision.
Fig. 1 Test information
function for the 34 items in the
final model and information on
the two original QLQ-C30
cognitive functioning (CF)
items. CF scores for all response
options (ranging from ‘not at
all’ to ‘very much’) are
presented and their level of
measurement precision
Fig. 2 Correlations and root
mean square errors (RMSEs) of
h’s based on fixed-length CATs
and the cognitive functioning
score based on all 34 items. For
example, scores based on three
or more items correlated highly
([0.90) with the score based on
all items
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However, from a clinical point of view this may be
irrelevant, because a very low level of cognitive diffi-
culties may not be different from ‘normality,’ and there
are no treatment implications for patients with no or
minor cognitive difficulties. Overall, the measurement
precision of the item bank was much higher than the two
original QLQ-C30 CF items alone, across the whole
continuum, although this may partially be explained by
including items that are similar in content.
Of the 34 items, 11 items focus on concentration and 23
items on memory. This imbalance was not caused by the
exclusion of items in the validation process, as only two
items on concentration and eight on memory were dis-
carded. To guarantee content balance, CAT may be pro-
grammed to systematically select items from both
subdomains. A simple solution to ensure direct coverage of
both subdomains would be to start a CAT by asking the
two original QLQ-C30 CF items. To fit the content covered
by the two QLQ-C30 CF items, this item bank also narrows
its coverage to concentration and memory, while cognitive
functioning comprises more domains [42]. On the other
hand, limiting the coverage to the original domains will
allow direct comparability with other studies that used the
QLQ-C30 to assess HRQoL.
Evaluations of known groups on observed data indicated
that using CAT resulted in large savings in study sample
sizes, around 50% for CATs of all lengths, as compared to
the original QLQ-C30 CF scale, without loss of power.
When the sample size would be further reduced, this would
be at the expense of statistical power. Simulated data
showed somewhat smaller savings, of up to 25%. Although
estimated savings varied between the observed and simu-
lated data, sample sizes will already be significantly
reduced, on average by 35–40%, when asking at least two
items (corresponding to 6% of the CF item bank). Thus,
fewer patients would need to be included in studies with
cognitive complaints as the primary endpoint. Moreover,
response burden for patients may be reduced, as a 1-item
CAT can result in a better estimation of CF than the
original 2-item QLQ-C30 CF sum scale.
In conclusion, we have developed a CF item bank for CAT
measurement consisting of 34 items, applicable to patients
with various cancer diagnoses, across different countries. The
item bank showed good psychometric properties. Moreover,
by tailoring the item set to the individual patients, measure-
ment precision is enhanced and the response burden possibly
reduced. When CAT versions for all QLQ-C30 scales are
developed, resulting in a complete EORTC QLQ-C30 CAT
instrument, these remain to be validated in an independent
dataset. Currently, the EORTC Quality of Life Group has
initiated such a large validation study.
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Fig. 3 The average relative
validity (RV) and relative
required sample size using CAT
measurement across observed
and simulated data, compared to
using the QLQ-C30 cognitive
functioning sum scale. For
example, using a CAT with two
items, the data show that the
validity of CAT is 1.24 times
that of the QLQ-C30 cognitive
functioning sum scale
(RV = 1.24). Moreover, the
required sample size is 37%
(sample size = 0.63) smaller
using this two-item CAT when
compared to the QLQ-C30
cognitive functioning sum scale,
while obtaining the same power
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